A twelve-week period of follow-up after an end of treatment response (ETR) to antiviral therapy in patients with chronic hepatitis C (CH-C) is a reliable period to characterize a sustained response (2002)
- Authors:
- USP affiliated authors: CARRILHO, FLAIR JOSE - FM ; NITA, SUZANE KIOKO ONO - FM
- Unidade: FM
- Subjects: HEPATOPATIAS; GASTROENTEROLOGIA
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2002
- Source:
- Título: Hepatology/ Official Journal of the American for the Study of Liver Diseases
- Volume/Número/Paginação/Ano: v. 36, n. 4
- Conference titles: AASLD Annual Meeting and Postgraduate Courses
-
ABNT
SILVA, Luiz C. da et al. A twelve-week period of follow-up after an end of treatment response (ETR) to antiviral therapy in patients with chronic hepatitis C (CH-C) is a reliable period to characterize a sustained response. Hepatology/ Official Journal of the American for the Study of Liver Diseases. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 08 jan. 2025. , 2002 -
APA
Silva, L. C. da, Medeiros-Filho, J. E. M., Pinho, J. R. R., Ono-Nita, S. K., & Carrilho, F. J. (2002). A twelve-week period of follow-up after an end of treatment response (ETR) to antiviral therapy in patients with chronic hepatitis C (CH-C) is a reliable period to characterize a sustained response. Hepatology/ Official Journal of the American for the Study of Liver Diseases. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Silva LC da, Medeiros-Filho JEM, Pinho JRR, Ono-Nita SK, Carrilho FJ. A twelve-week period of follow-up after an end of treatment response (ETR) to antiviral therapy in patients with chronic hepatitis C (CH-C) is a reliable period to characterize a sustained response. Hepatology/ Official Journal of the American for the Study of Liver Diseases. 2002 ; 36( 4):[citado 2025 jan. 08 ] -
Vancouver
Silva LC da, Medeiros-Filho JEM, Pinho JRR, Ono-Nita SK, Carrilho FJ. A twelve-week period of follow-up after an end of treatment response (ETR) to antiviral therapy in patients with chronic hepatitis C (CH-C) is a reliable period to characterize a sustained response. Hepatology/ Official Journal of the American for the Study of Liver Diseases. 2002 ; 36( 4):[citado 2025 jan. 08 ] - Revisão sistemática de literatura da comparação da eficácia do tratamento da hepatite C crônica em estudos randomizados-controlados e "estudos de vida real": Influências do tipo de desenhos de estudos nas respostas virológicas sustentadas
- Four years real-life experience with antiviral adherence in chronic hepatitis B infection in a tertiary university hospital
- Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review
- Development of Hepatitis C Virus Genotyping by Real-Time PCR Based on the NS5B Region
- Radiofreqüência no tratamento do carcinoma hepatocelular: resultados preliminares
- Farmacogenética em oncologia gastrotrintestinal
- Genetic Risk for Alcoholic Chronic Pancreatitis
- Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the Southwest Parana State, Brazil
- Fisiologia hepática
- Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
